TipRanks
Athens Medical Center SA (GB:0ONM)
LSE:0ONM
UK Market
0ONM
Athens Medical Center
RESEARCH TOOLSreports

Athens Medical Center (0ONM) Ratios

0 Followers

Athens Medical Center Ratios

GB:0ONM's free cash flow for Q2 2026 was €0.20. For the 2026 fiscal year, GB:0ONM's free cash flow was decreased by € and operating cash flow was €0.06. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.97 0.76 0.83 0.98 1.10
Quick Ratio
 0.94 0.74 0.80 0.95 1.05
Cash Ratio
 0.07 0.11 0.08 0.11 0.11
Solvency Ratio
 0.04 0.03 0.05 0.06 0.07
Operating Cash Flow Ratio
 -0.01 0.02 0.20 0.13 <0.01
Short-Term Operating Cash Flow Coverage
 -0.07 0.05 0.82 0.52 <0.01
Net Current Asset Value
€ -213.61M€ -209.12M€ -195.18M€ -171.58M€ -155.01M
Leverage Ratios
Debt-to-Assets Ratio
 0.34 0.34 0.30 0.33 0.34
Debt-to-Equity Ratio
 1.76 1.76 1.36 1.46 1.40
Debt-to-Capital Ratio
 0.64 0.64 0.58 0.59 0.58
Long-Term Debt-to-Capital Ratio
 0.55 0.37 0.39 0.45 0.52
Financial Leverage Ratio
 5.22 5.13 4.57 4.39 4.05
Debt Service Coverage Ratio
 0.53 0.24 0.44 0.54 1.11
Interest Coverage Ratio
 0.39 0.34 1.43 2.44 2.37
Debt to Market Cap
 1.32 0.93 0.97 0.87 1.04
Interest Debt Per Share
 2.27 2.23 1.82 1.94 1.75
Net Debt to EBITDA
 5.66 5.44 4.06 3.61 3.95
Profitability Margins
Gross Profit Margin
20.28%20.36%22.52%25.76%24.34%
EBIT Margin
3.01%3.02%5.63%8.85%7.88%
EBITDA Margin
10.58%10.08%11.86%14.63%13.82%
Operating Profit Margin
1.78%1.41%5.65%8.94%7.89%
Pretax Profit Margin
-1.37%-1.09%1.67%5.30%4.59%
Net Profit Margin
-1.89%-1.69%0.66%3.13%2.93%
Continuous Operations Profit Margin
-1.89%-1.67%0.70%3.16%2.96%
Net Income Per EBT
138.25%155.25%39.59%58.99%63.90%
EBT Per EBIT
-76.82%-77.27%29.46%59.31%58.21%
Return on Assets (ROA)
-0.98%-0.88%0.36%1.69%1.64%
Return on Equity (ROE)
-5.11%-4.49%1.64%7.44%6.63%
Return on Capital Employed (ROCE)
1.61%1.59%5.75%8.34%6.75%
Return on Invested Capital (ROIC)
1.42%1.11%1.95%4.12%4.02%
Return on Tangible Assets
-0.99%-0.89%0.36%1.70%1.64%
Earnings Yield
-4.20%-2.72%1.36%4.98%5.56%
Efficiency Ratios
Receivables Turnover
 1.52 1.59 1.69 1.64 1.83
Payables Turnover
 1.78 1.82 2.01 2.12 2.20
Inventory Turnover
 27.76 28.04 29.01 27.63 25.22
Fixed Asset Turnover
 0.92 0.92 0.92 0.95 0.92
Asset Turnover
 0.52 0.52 0.54 0.54 0.56
Working Capital Turnover Ratio
 -7.56 -5.16 -12.79 46.92 11.00
Cash Conversion Cycle
 48.59 42.10 46.16 63.80 48.62
Days of Sales Outstanding
 240.35 229.41 215.43 223.09 199.77
Days of Inventory Outstanding
 13.15 13.02 12.58 13.21 14.48
Days of Payables Outstanding
 204.91 200.33 181.85 172.50 165.63
Operating Cycle
 253.50 242.43 228.01 236.30 214.25
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.04 0.06 0.54 0.30 <0.01
Free Cash Flow Per Share
 -0.22 -0.14 0.23 0.04 -0.18
CapEx Per Share
 0.19 0.20 0.31 0.26 0.18
Free Cash Flow to Operating Cash Flow
 6.32 -2.33 0.43 0.15 -127.02
Dividend Paid and CapEx Coverage Ratio
 -0.19 0.30 1.64 1.17 <0.01
Capital Expenditure Coverage Ratio
 -0.19 0.30 1.74 1.17 <0.01
Operating Cash Flow Coverage Ratio
 -0.02 0.03 0.32 0.17 <0.01
Operating Cash Flow to Sales Ratio
 -0.01 0.02 0.17 0.10 <0.01
Free Cash Flow Yield
-15.30%-6.89%15.13%2.35%-12.79%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -23.82 -36.80 73.66 20.07 17.99
Price-to-Sales (P/S) Ratio
 0.45 0.62 0.49 0.63 0.53
Price-to-Book (P/B) Ratio
 1.21 1.65 1.21 1.49 1.19
Price-to-Free Cash Flow (P/FCF) Ratio
 -6.54 -14.52 6.61 42.57 -7.82
Price-to-Operating Cash Flow Ratio
 -41.29 33.75 2.82 6.20 993.27
Price-to-Earnings Growth (PEG) Ratio
 1.86 0.10 -0.94 1.11 -0.38
Enterprise Value Multiple
 9.91 11.62 8.15 7.90 7.77
Enterprise Value
 295.16M 322.85M 260.77M 298.74M 250.54M
EV to EBITDA
 9.91 11.62 8.15 7.90 7.77
EV to Sales
 1.05 1.17 0.97 1.16 1.07
EV to Free Cash Flow
 -15.23 -27.29 13.16 78.41 -15.91
EV to Operating Cash Flow
 -96.24 63.45 5.61 11.42 2.02K
Tangible Book Value Per Share
 1.12 1.11 1.18 1.22 1.18
Shareholders’ Equity Per Share
 1.20 1.20 1.25 1.25 1.19
Tax and Other Ratios
Effective Tax Rate
 -0.38 -0.54 0.58 0.40 0.35
Revenue Per Share
 3.25 3.18 3.11 2.98 2.69
Net Income Per Share
 -0.06 -0.05 0.02 0.09 0.08
Tax Burden
 1.38 1.55 0.40 0.59 0.64
Interest Burden
 -0.45 -0.36 0.30 0.60 0.58
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.17 0.03 0.03 0.02 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.84 -1.69 10.33 3.24 0.01
Currency in EUR